glp 1 drugs for cardiovascular health GLP-1 medications can protect the heart – eve… From Fat Burn to Muscle

Patel, V

The question of whether weight loss on top of great medical therapy can lower events has been answered, and the effect is impressive

9 The consensus statement from the American Association of Clinical Endocrinologists supports the use of GLP-1 RAs as first-line therapy in managing hyperglycaemia in T2D patients with established (or at high risk of) atherosclerotic CVD, as well as in those with chronic kidney disease or a history of stroke or transient ischaemic attack, while recommending the administration of sodiumglucose cotransporter 2 inhibitors to HF patients

Individual patient risk factors likely play a more significant role than the medication itself in determining pancreatitis susceptibility

Effect of dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist on weight loss in subjects with obesity

You are not expecting a magic pill